David Malkin, James Whitlock

Published purpose

The specific objectives of this funding opportunity are to: • Establish a multi-stakeholder Pediatric Cancer Consortium which covers the cancer control continuum from prevention to diagnosis, treatment to survivorship that encompasses the breadth of stakeholders and knowledge-users with a transparent, inclusive multi-jurisdictional recruitment and membership process, meaningful engagement with partners and innovative international research collaborations. • Advance pediatric cancer research through platforms and projects in high priority areas. • Improve the research pipeline for the development and further access to drugs for children affected by cancer and their families, by working in the context of regulatory frameworks (Health Canada) for drug approval processes and, with engagement of people with lived/living experience (PWLLE), influencing system improvements through research and knowledge mobilization. • Advance equitable access to new and promising therapies regardless of geography, race/ethnicity, and socioeconomic status. • Build capacity for the next generation of pediatric cancer researchers through training and mentorship opportunities embedded and interconnected across the Consortium and capacity for people with lived and living experience to engage meaningfully in the research ecosystem. • Maximize research impact and knowledge mobilization within and beyond the Consortium to help ensure evidence is integrated in and used to inform health policy, decision making and planning.